1. Introduction {#sec1}
===============

There is growing scientific and clinical interest in the interactions between obesity and thyroid function \[[@bib1]\]. Thyroid hormones are known to be involved in key metabolic pathways in the regulation of basal metabolism and energy expenditure, and also have a role in lipid and glucose metabolism \[[@bib2]\]. Thyroid dysfunction has been reported in patients with obesity, although there are conflicting reports on whether the levels of various thyroid hormones are normal, elevated or low in patients with obesity \[[@bib3]\]. In most studies, however, a high body mass index (BMI) was found to be associated with elevated serum levels of thyroid stimulating hormone (TSH) and low serum levels of thyroxine (T4) \[[@bib4],[@bib5]\].

The interactions between thyroid hormone levels, body composition (i.e. fat mass and free fat mass), and insulin resistance have not been extensively characterized. Serum TSH levels were positively associated with visceral adiposity \[[@bib6]\] and higher insulin resistance in both men and women, whereas elevated serum FT3 levels were significantly associated with a low lean mass \[[@bib7]\]. The mechanisms underlying these findings are not well understood \[[@bib3]\]. Given that the thyroid hormones T3 and T4 regulate resting energy expenditure, changes in thyroid hormone levels might suggest that the body is adapting to obesity \[[@bib8]\]. Furthermore, caloric restriction may induce alterations in peripheral thyroid hormone metabolism (e.g. low type II deiodinase activity) \[[@bib9]\].

The impact of weight change on thyroid function has been explored in several observational studies, although the results were inconsistent \[[@bib5],[@bib10],[@bib11]\]. For example, a caloric restriction diet has been linked to a low serum T3 concentration in lean and weight-stable healthy humans \[[@bib12]\]. In patients with obesity, weight loss was associated with a decrease in TSH and T3 levels (relative to baseline levels), regardless of the weight loss strategy used (caloric restriction or bariatric surgery) \[[@bib13], [@bib14], [@bib15]\]. In contrast, Reinehr et al. evidenced a long-term decrease in thyroid hormones (but not TSH) among children with obesity having lost weight after a year on a normal-calorie diet \[[@bib16]\].

It is well established that exercise may promote modest weight loss, and also has an important role in weight regain after initial weight loss. Furthermore, clinical trials of exercise that report no weight loss or modest weight loss (\<5 kgs) still report numerous health benefits for overweight and obese adults. These benefits include improving cardiorespiratory fitness, glucose control, endothelial function and quality of life \[[@bib17]\].

There are few literature data on the impact of a combination of exercise and diet on thyroid function. Here, we report the results of a study designed to characterize the mid-term thyroid response to a supervised "exercise plus diet" obesity rehabilitation program.

2. Patients and methods {#sec2}
=======================

2.1. Design and setting {#sec2.1}
-----------------------

The study was carried out in the Department of Rehabilitation, Nutrition and Obesity at Berck Maritime Hospital (Berck, France). Most of the Department\'s patients are referred by nutrition and endocrinology departments throughout northern France. Inpatients with obesity (BMI \>30 kg/m^2^) were invited to participate in the study. All participants provided their informed consent prior to inclusion. The protocol conformed with the principles outlined by the Declaration of Helsinki and was approved by the local ethics committee in Berck. Each participant acted as his/her own control. Participants with a history of thyroid disease, positivity for thyroid autoantibodies, and use of thyroid hormones or iodine-containing drugs were excluded.

2.2. The diet and exercise program {#sec2.2}
----------------------------------

The multidisciplinary inpatient diet and exercise program is summarized in [Fig. 1](#fig1){ref-type="fig"}. All participants had an initial one-to-one consultation with a clinical dietician, and then followed a normal-calorie diet. Energy needs were estimated using the Mifflin-St Jeor equation \[[@bib18]\]. In energy terms, the diet comprised 55% carbohydrate, 30% fat, and 15% protein. All meals were prepared and provided in our department throughout the three-month program. Clinical dieticians offered individual and group-based dietary counseling on a weekly basis.Fig. 1The 3-month rehabilitation program.BIA: bio-electrical impedance analysis.Fig. 1

The group-format exercise program involved aerobic exercise training (5 days a week). Patients had every day: two 30-min sessions of land-based exercise in our training room and one 45 min water-based aerobics class (indoor swimming pool). Groups of 4--8 participants performed exercise at 70--80% of their maximum heart rate, with a focus on improving skeletal muscle strength, endurance ability (including walking, cycling and swimming), flexibility, and balance (Pilates-inspired exercise). All exercise sessions were developed and supervised by certified trainers and physiotherapists.

2.3. Body composition and thyroid hormone assays {#sec2.3}
------------------------------------------------

Clinical, biochemical, and body composition variables were measured before and at the end of the 3-month rehabilitation program. Fasting serum TSH, free T3 and free T4 concentrations were measured using a chemiluminescence immunoassay (ADVIA Centaur XP Immunoassay System, Siemens, USA). Body composition was measured in a bio-electrical impedance analysis (Tanita BC-418 MA, Tanita Corporation).

2.4. Statistical analyses {#sec2.4}
-------------------------

Statistical analyses were performed with SPSS software (version 10.0; SPSS, Chicago, IL, USA). Data were quoted as the mean ± standard deviation (SD). Changes in clinical and biochemical variables between baseline and at the end of the intervention were assessed in a paired *t*-test. Spearman\'s test was used to identify correlations between changes in body weight or composition and thyroid parameters. The threshold for statistical significance was set to p \< 0.05.

3. Results {#sec3}
==========

A total of 34 consecutive participants in the rehabilitation program (mean age: 51 ± 12 years) were included in the study. The participants' demographic and clinical characteristics and pre-/post-intervention changes are summarized in [Table 1](#tbl1){ref-type="table"}. All participants tested negative for thyroid antibodies, and had serum TSH levels within the reference range. At baseline, there were no significant sex-related differences in the correlations between thyroid function tests on one hand and clinical variables or body composition on the other (data not shown). At the end of the 3-month rehabilitation program, all the participants presented a substantial body weight loss (mean ± value: 11 kg, *p \< *0.05); this was mainly due to fat mass loss (mean loss: 6.8 kg, *p \< *0.05). The mean BMI was 49.3 ± 12.4 kg/m^2^ before the program and 46 ± 10.8 kg/m^2^ afterwards (*p \< *0.05). A small but significant decrease in glycated hemoglobin (HbA1C) was observed (6 ± 0.8 before and 5.8 ± 0.6 after, *p \< *0.05).Table 1Participants' clinical and biochemical characteristics.Table 1VariablesBaselinePost intervention*P-*valuen3434-Gender (M/F)18/1618/16-Age (years)51 ± 1251 ± 12-Body weight (kg)138.7 ± 38127.7 ± 32\<0.05Mean BMI (kg/m^2^)49.3 ± 12.446 ± 10.8\<0.05Body fat (%)45.4 ± 9.243.5 ± 9.8\<0.05Fat mass (kg)60.1 ± 20.653.3 ± 18.3\<0.05Lean mass (fat-free mass) (kg)70.6 ± 1768.3 ± 16.4\<0.05Estimated resting energy expenditure (kcal/day)22262135\<0.05HbA1C (%)6 ± 0.85.8 ± 0.6\<0.05TSH (mUI/L) (N: 0.4--4)1.72 ± 0.71.89 ± 0.860.2649Free T4 (ng/dl) (N: 0.80--1.90)1.06 ± 0.191.04 ± 0.170.9490Free T3 (pg/ml) (N: 1.80--4.20)2.92 ± 0.372.87 ± 0.390.1852Serum Albuminemia (g/l)37.8 ± 4.238.1 ± 3.50.3304Serum Creatininemia (mg/l)8 ± 1.78.2 ± 1.40.0543[^1]

There were no significant pre-/post-differences in thyroid hormone levels. Moreover, the weight loss at the end of the intervention was not significantly correlation with the concentrations of TSH (r = 0.25, *P* = 0.17), FT3 (r = -0.01; *P* = 0.94) or FT4 (*r* = -0.43, *P* = 0.05). Likewise, there were no significant correlations between the change in fat mass and the concentrations of TSH (*r* = 0.40; *P* = 0.05), FT3 (*r* = −0.16, *P* = 0.52) or FT4 (*r* = -0.39, *P* = 0.13).

4. Discussion {#sec4}
=============

The present study generated two important findings. Firstly, there was no association between baseline thyroid function (i.e. TSH, FT4 and FT3 concentrations) and BMI or body composition. This is in line with some studies \[[@bib19]\], whereas others have reported a correlation between the percentage body fat and the TSH level \[[@bib20],[@bib21]\].

Secondly, thyroid function did not change significantly over the course of the intervention, despite significant weight loss and a fall in BMI. This finding contrasts with Marzullo et al.'s report that weight loss during a 4-week inpatient dieting program was associated with significantly falls in levels of TSH (6.3%), FT3 (3.3%) and FT4 (3.9%; p \< 0.001 for all) in 70 patients with obesity \[[@bib22]\].

Exercise may affect the hormonal production of many endocrine glands \[[@bib23]\]. In line with our study findings, changes in thyroid hormone levels in response to exercise, are in general, small and within the normal range \[[@bib24]\]. Increase, decrease, or no change in the levels of thyroid hormones has been reported, regardless of the type of exercise, duration, and intensity \[[@bib25], [@bib26], [@bib27]\]. These divergent findings might be attributed to several confounding factors, such as variations in body composition, nutritional status and the type of exercise training \[[@bib24]\].

It is important to note that the significant body weight loss and fat loss (with mean values of 11 kg and 6.8 kg, respectively) observed in the present study were associated with improved body composition and a reduction in insulin resistance (as indicated by a fall in HbA1C levels, *p \< *0.05). Furthermore, we also observed a moderate but nevertheless significant decrease in the lean mass (mean value: 2.3 kg). Interestingly, resting energy expenditure and levels of the biomarker serum albumin (reflecting protein and nutritional status) did not change significantly during the program. There are several possible explanations for this stability. Firstly, it has been shown that an exercise plus diet combination reduces muscle mass loss and increases muscle strength during voluntary weight loss in people with obesity \[[@bib28]\]. Secondly, insulin is a powerful driver of muscle protein synthesis; hence, the observed decrease in obesity-related insulin resistance after the exercise-diet program might help to preserve muscle mass and resting energy expenditure \[[@bib29]\]. Considering that most metabolic processes (energy expenditure, and glucose and lipid homeostasis) occur within the lean mass compartment (i.e. muscle), the relative stability of protein and nutritional status might explain why the thyroid function parameters did not change markedly \[[@bib30]\]. We hypothesize that the significant fat mass loss and stable protein and nutritional status observed in our study are related to the provision of an individualized, normal-calorie diet and an appropriate physical activity program.

Our study had a number of strengths -- notably its prospective and longitudinal design. Moreover, the study personnel supervised the protocol rigorously, and ensured that patients complied with the dietary and exercise-related recommendations. This close supervision enabled us to reliably evaluate changes over time, with each participant serving as his/her control.

Our study also had some limitations. Firstly, only participants with grade III obesity (BMI \>40 kg/m^2^) and a normal serum TSH level were included. It is not therefore possible to generalize the results to other obesity phenotypes or to patients with patent thyroid dysfunction. Secondly, we did not measure levels of hormones or peptides that can be influenced by a weight change (e.g. leptin and ghrelin). Although leptin and TSH levels are reportedly correlated in people with obesity \[[@bib5]\], this relationship is subject to debate \[[@bib2],[@bib21]\].

Unfortunately, the nature of our ward and the patients profile do not allow us to use control group with either diet therapy alone or exercise therapy alone.

In conclusion, our results showed that a 3-month individualized rehabilitation program combining diet and exercise enhanced weight loss without inducing significant thyroid function changes in patients with severe obesity. Further research is warranted to clarify the underlying relationship between thyroid function and body weight change in this population.
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[^1]: All values expressed as mean ± SD.
